CRDF
Cardiff Oncology Inc
1.20$
-3.1%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
Cardiff Oncology Inc (CRDF) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -38 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2005 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -4.4 | -1.2 | -2.1 | -1.9 | -4.9 | -7.3 | -13 | -22 | -31 | -23 | -13 | -13 | -16 | -23 | -34 | -31 | -38 | -38 | |
| 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.1 | 0.2 | 0.4 | 1.1 | 1.2 | 0.9 | 0.5 | 0.5 | 0.5 | 0.2 | 0.4 | 0.4 | 0.9 | |
| 3.6 | – | 0.3 | 0.3 | 0.5 | 2.0 | 2.1 | 3.9 | 7.5 | 4.0 | 2.2 | 0.9 | 1.8 | 3.2 | 4.3 | 4.5 | 4.8 | 5.7 | |
| – | – | – | – | – | 3.1 | 0.6 | 4.7 | 5.6 | 3.3 | 2.1 | 0.9 | 2.1 | 3.0 | 4.3 | – | – | – | |
| 0.0 | -0.4 | 0.0 | 0.6 | -0.8 | 1.1 | 0.4 | -0.1 | 1.1 | -3.1 | 0.1 | 1.1 | -0.7 | -1.8 | -0.4 | 6.6 | 3.2 | 2.2 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.3 | 0.6 | 0.4 | 2.2 | 0.8 | 0.1 | 0.0 | 0.1 | 0.2 | 0.2 | 0.9 | 0.6 | 0.1 | 0.0 | |
| -0.1 | 0.0 | -0.1 | 0.0 | -0.3 | -0.6 | -0.3 | -2.2 | -25 | 24 | 0.0 | -0.1 | -0.2 | -131 | 38 | 36 | 14 | 1.3 | |
| 0.1 | – | – | – | – | – | 23 | 24 | 24 | 24 | 24 | 24 | 24 | 0.0 | 0.4 | – | – | – | |
| – | 1.5 | – | – | – | 22 | – | 63 | 24 | 25 | 32 | 12 | 24 | 35 | 0.1 | – | – | – | |
| – | – | – | – | – | 0.5 | 14 | 1.1 | -0.4 | -17 | -1.4 | – | – | 0.0 | – | – | – | – | |
| 5.1 | 1.7 | 1.7 | 2.6 | 15 | 23 | 14 | 65 | 2.3 | -6.4 | 16 | 12 | 137 | 35 | 0.1 | 0.0 | 54 | 2.6 | |
| 0.6 | 0.4 | -0.5 | 0.6 | 10 | 15 | 1.5 | 40 | -54 | -5.7 | 3.2 | -1.3 | 121 | -119 | 4.4 | 5.3 | 30 | -34 | |
| -4.4 | -1.2 | -2.1 | -1.9 | -5.2 | -8.0 | -13 | -24 | -32 | -23 | -13 | -13 | -17 | -23 | -35 | -31 | -38 | -38 |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.